Wellington Management Group’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,936
Closed -$564K 2124
2022
Q2
$564K Hold
11,936
﹤0.01% 1803
2022
Q1
$740K Buy
11,936
+35
+0.3% +$2.88K ﹤0.01% 1795
2021
Q4
$1.51M Sell
11,901
-9,158
-43% -$1.5M ﹤0.01% 1725
2021
Q3
$4.2M Buy
21,059
+1,730
+9% +$412K ﹤0.01% 1545
2021
Q2
$5.12M Buy
19,329
+13,844
+252% +$4.28M ﹤0.01% 1504
2021
Q1
$1.92M Buy
5,485
+1,655
+43% +$707K ﹤0.01% 1632
2020
Q4
$1.96M Hold
3,830
﹤0.01% 1496
2020
Q3
$1M Sell
3,830
-619
-14% -$213K ﹤0.01% 1551
2020
Q2
$2.43M Sell
4,449
-1,952
-30% -$878K ﹤0.01% 1327
2020
Q1
$2.02M Buy
+6,401
New +$2M ﹤0.01% 1358

Other funds holding PASG

Wellington Management Group's PASG Position: Q3 2022 in Review

Wellington Management Group sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 11,936 shares — an estimated $564K sold.

Wellington Management Group first reported a position in PASG in Q1 2020 and held it in 10 quarters. The position peaked at $5.12M in Q2 2021. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • Wellington Management Group reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • Wellington Management Group sold 11,936 Passage Bio shares in Q3 2022, an estimated $564K.
  • Wellington Management Group first reported a position in Passage Bio in Q1 2020 and held it in 10 quarters.
  • Wellington Management Group's Passage Bio position peaked at $5.12M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on Wellington Management Group's 13F filing for Q3 2022, filed 14 Nov 2022.